GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Heartware International Inc (NAS:HTWR) » Definitions » ROC %

Heartware International (Heartware International) ROC % : -13.38% (As of Jun. 2016)


View and export this data going back to 2008. Start your Free Trial

What is Heartware International ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Heartware International's annualized return on capital (ROC %) for the quarter that ended in Jun. 2016 was -13.38%.

As of today (2024-06-16), Heartware International's WACC % is 0.00%. Heartware International's ROC % is 0.00% (calculated using TTM income statement data). Heartware International earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Heartware International ROC % Historical Data

The historical data trend for Heartware International's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heartware International ROC % Chart

Heartware International Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
ROC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -82.54 -119.62 -38.99 -0.07 -21.69

Heartware International Quarterly Data
Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.16 -55.22 11.29 -35.42 -13.38

Heartware International ROC % Calculation

Heartware International's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2015 is calculated as:

ROC % (A: Dec. 2015 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2014 ) + Invested Capital (A: Dec. 2015 ))/ count )
=-37.246 * ( 1 - -1.41% )/( (195.421 + 152.86)/ 2 )
=-37.7711686/174.1405
=-21.69 %

where

Invested Capital(A: Dec. 2014 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=423.813 - 49.911 - ( 178.481 - max(0, 49.911 - 276.543+178.481))
=195.421

Invested Capital(A: Dec. 2015 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=457.576 - 61.138 - ( 243.578 - max(0, 61.138 - 329.702+243.578))
=152.86

Heartware International's annualized Return on Capital (ROC %) for the quarter that ended in Jun. 2016 is calculated as:

ROC % (Q: Jun. 2016 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2016 ) + Invested Capital (Q: Jun. 2016 ))/ count )
=-25.456 * ( 1 - -1.85% )/( (193.876 + 193.624)/ 2 )
=-25.926936/193.75
=-13.38 %

where

Invested Capital(Q: Jun. 2016 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=429.372 - 50.526 - ( 185.222 - max(0, 50.526 - 267.191+185.222))
=193.624

Note: The Operating Income data used here is four times the quarterly (Jun. 2016) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Heartware International  (NAS:HTWR) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Heartware International's WACC % is 0.00%. Heartware International's ROC % is 0.00% (calculated using TTM income statement data). Heartware International earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Heartware International ROC % Related Terms

Thank you for viewing the detailed overview of Heartware International's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Heartware International (Heartware International) Business Description

Traded in Other Exchanges
N/A
Address
Heartware International Inc was incorporated in Delaware on July 29, 2008 and became the successor issuer to HeartWare Limited, an Australian corporation, on November 13, 2008, as a result of the Australian Court approved redomiciliation of HeartWare Limited from Australia to Delaware. HeartWare is a medical device company engaged in developing implantable blood pumps for the treatment of advanced heart failure. The Company operates one reportable segment which includes the design, manufacture and marketing of medical devices for the treatment of advanced heart failure. The HeartWare Ventricular Assist System, which includes a left ventricular assist device, or blood pump, patient accessories and surgical tools, is designed to provide circulatory support for patients with advanced heart failure. Beyond the HeartWare System, the company is also evaluating its next device, the Miniaturized Ventricular Assist Device. The MVAD is based on the same technology platform as the HeartWare System but adopts an axial flow, rather than a centrifugal flow, configuration and is being developed in multiple configurations. The MVAD designs are currently at the preclinical stage and undergoing animal studies focused on minimally invasive implantation techniques and are each approximately one-third the size of the HVAD Pump. The Company's competitors in the implantable cardiac assist space include Thoratec Corporation, Jarvik Heart, Inc., MicroMed Cardiovascular, Berlin Heart GmbH, and Sunshine Heart, Inc. HEARTWARE, HVAD, MVAD, PAL, CIRCULITE, SYNERGY and various company logos are the trademarks of the Company, in the United States, Europe, Australia and other countries.
Executives
Larkin C Raymond Jr director C/O MALLINCKRODT INC, 7733 FORSYTH BLVD, ST LOUIS MO 63105
Stephen N. Oesterle director ONE BAXTER PARKWAY, DEERFIELD IL 60015
Cynthia L Feldmann director 17 WINTHROP ROAD, WAYLAND MA 01778
Seth Loring Harrison director 230 PARK AVENUE, SUITE 2800, NEW YORK NY 10169
Timothy J Barberich director 40 ELM ST, CONCORD MA 01752
Douglas Evan Godshall director, officer: President & Chief Exec Officer SUITE 4 LEVEL 46 2 PARK STREET, SIDNEY C3 2000
Robert Bain Thomas director SUITE 4 LEVEL 46 2 PARK STREET, SIDNEY C3 2000
Denis Newell Wade director SUITE 4 LEVEL 46, 2 PARK STREET, SIDNEY C3 2000
Adage Capital Partners Gp, L.l.c. 10 percent owner 200 CLARENDON STREET, 52ND FLOOR, BOSTON MA 02116
Adage Capital Partners, L.p. 10 percent owner 200 CLARENDON STREET, 52ND FLOOR, BOSTON MA 02116
Adage Capital Advisors, L.l.c. 10 percent owner 200 CLARENDON STREET, 52ND FLOOR, BOSTON MA 02116
Robert Atchinson 10 percent owner 200 CLARENDON STREET, 52ND FLOOR, BOSTON MA 02116
Phillip Gross 10 percent owner 200 CLARENDON STREET, 52ND FLOOR, BOSTON MA 02116
David Mcintyre officer: CFO & COO SUITE 4 LEVEL 46 2 PARK STREET, SIDNEY C3 2000
Muneer A Satter 10 percent owner C/O SATTER INVESTMENT MANAGEMENT, LLC, 676 NORTH MICHIGAN AVENUE, SUITE 4000, CHICAGO IL 60611

Heartware International (Heartware International) Headlines

From GuruFocus

Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 21,834 Shares

By GuruFocus Research GuruFocus Editor 04-30-2010

Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 2,521 Shares

By GuruFocus Research GuruFocus Editor 12-08-2009

Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 2,857 Shares

By GuruFocus Research GuruFocus Editor 02-24-2011

Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 3,415 Shares

By GuruFocus Research GuruFocus Editor 11-25-2009

Baron Funds Comments on HeartWare International

By Holly LaFon 05-05-2014

Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 1,000 Shares

By GuruFocus Research GuruFocus Editor 11-19-2009

Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 3,300 Shares

By GuruFocus Research GuruFocus Editor 02-27-2010

Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 5,271 Shares

By GuruFocus Research GuruFocus Editor 03-09-2010

Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 4,967 Shares

By GuruFocus Research GuruFocus Editor 01-30-2010

Heartware International Inc (HTWR) CFO & COO David Mcintyre sells 3,400 Shares

By GuruFocus Research GuruFocus Editor 12-01-2009